Position in HALO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$113,413
+$19,765 QoQ
Shares Held
1,449
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#517
of 664 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SITTNER & NELSON, LLC holds $972,877 across 13 Biotechnology names. HALO ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
615 | $305,488 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
4,801 | $261,846 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
2,550 | $145,911 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,449 | $113,413 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
95 | $59,236 | |
| 6 | MRNA |
Moderna, Inc.
|
650 | $45,519 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
75 | $14,046 | |
| 8 | BNTX |
BioNTech SE
|
100 | $9,305 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,413 | 1,449 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $93,648 | 1,449 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||